Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

This document is a response to public comments on the MolDX LCD L38647 regarding prognostic and predictive molecular classifiers for bladder cancer and records the comment and notice periods (comment period 05/28/2020–07/12/2020; notice begins 06/10/2021; effective 07/25/2021). The response document itself does not state clinical coverage indications, limitations, or claim documentation requirements; refer to LCD L38647 for the complete coverage criteria.

"This document is a response to comments for the MolDX Local Coverage Determination L38647 (Prognostic and Predictive Molecular Classifiers for Bladder Cancer); comment period 2020-05-28 to 2020-07-..."

Sign up to see full coverage criteria, indications, and limitations.